Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Anemia

Free Subscription Articles published in Ann Hematol Retrieve available abstracts of 143 articles: HTML format

Single Articles

April 2025
1. TAYLOR KJ, Singer S, Langemeijer S, Kelly RJ, et al
   What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria?
   Ann Hematol. 2025 Apr 29. doi: 10.1007/s00277-025-06377.
   PubMed    
   
   
   
2. LIU X, Chai X, Yu Q, Wang W, et al
   Clinical features and outcomes in large granular lymphocyte leukemia - associated pure red cell aplasia with STAT3 mutation.
   Ann Hematol. 2025 Apr 23. doi: 10.1007/s00277-025-06371.
   PubMed     Abstract available
   
   
   
3. CHEN T, Song J, Xing L, Chen J, et al
   From severe aplastic anemia with TERT variant to Wilson disease - associations or not.
   Ann Hematol. 2025 Apr 21. doi: 10.1007/s00277-025-06370.
   PubMed     Abstract available
   
   
   
4. LI J, Shi Y, Zhang B, Yang W, et al
   The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia.
   Ann Hematol. 2025 Apr 7. doi: 10.1007/s00277-025-06335.
   PubMed     Abstract available
   
   
   
5. RAMESH M, Fakhari-Tehrani Y, Deenadayalan V, Padhi P, et al
   Impact of protein-energy malnutrition on outcomes of patients with sickle cell disease: an analysis of the National inpatient sample.
   Ann Hematol. 2025;104:2171-2177.
   PubMed     Abstract available
   
   
   
6. MANNING JE, Ciantar E, Griffin M, Kelly RJ, et al
   Paroxysmal nocturnal haemoglobinuria in pregnancy-a systematic review with meta analysis.
   Ann Hematol. 2025;104:2517-2525.
   PubMed     Abstract available
   
   
   
7. AL-AWADHI A, Alwehaidah MS, Al-Sabaan K, Al-Ajmi N, et al
   Assessment of ferritin and hepcidin levels in splenectomised and non-splenectomised beta-thalassemia major patients and exploring a potential correlation with von Willebrand factor and ADAMTS-13.
   Ann Hematol. 2025;104:2229-2238.
   PubMed     Abstract available
   
   
   
8. YUSUP M, He G, Qin Y, Tuerxun N, et al
   Efficacy and influencing factors of immunosuppressive therapy for pure red cell aplasia: meta-analysis and systematic review.
   Ann Hematol. 2025;104:2189-2206.
   PubMed     Abstract available
   
   
   
9. RODRIGUEZ NG, Franciss G, Perez E, Maryam Z, et al
   Understanding the role of asthma in acute chest syndrome: a comparative analysis of patients with and without asthma.
   Ann Hematol. 2025;104:2179-2187.
   PubMed     Abstract available
   
   
   
10. JIANG F, Wu J, Yang M, Chen X, et al
    An unusual transfusion-dependent hemoglobin H disease caused by a novel complex inverted duplication involving the alpha-globin regulatory elements and alpha-thalassemia--SEA deletion.
    Ann Hematol. 2025;104:2529-2535.
    PubMed     Abstract available
    
    
    March 2025
11. STEMPEL JM, Wang R, Lee AI, Zeidan AM, et al
    Initial management of patients with acquired aplastic anemia in the United States: results from a large national claims database.
    Ann Hematol. 2025 Mar 19. doi: 10.1007/s00277-025-06307.
    PubMed     Abstract available
    
    
    
12. ROMANELLO KS, da Silva JPMO, Torres FF, Teixeira KKL, et al
    Unraveling the multifaceted roles of peroxiredoxins in sickle cell anemia: implications in redox and inflammation adaptations.
    Ann Hematol. 2025 Mar 14. doi: 10.1007/s00277-025-06294.
    PubMed     Abstract available
    
    
    
13. LIU T, Fillbrunn M, Zhang S, Chen J, et al
    Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis.
    Ann Hematol. 2025 Mar 12. doi: 10.1007/s00277-025-06279.
    PubMed     Abstract available
    
    
    
14. REKAYA S, Ben Fraj I, Hamdi R, Ben Taieb A, et al
    Sideroblastic anemia in children: challenges in diagnosis and management in three cases.
    Ann Hematol. 2025 Mar 5. doi: 10.1007/s00277-025-06266.
    PubMed     Abstract available
    
    
    
15. KAWAKAMI T, Kawakami F, Matsuzawa S, Yamane T, et al
    Mutational heterogeneities in STAT3 and clonal hematopoiesis-related genes in acquired pure red cell aplasia.
    Ann Hematol. 2025;104:1471-1479.
    PubMed     Abstract available
    
    
    
16. KEESARI PR, Vegivinti CTR, Rajamanuri M, Mustafa A, et al
    Racial disparities in cardiovascular manifestations among patients with sickle cell trait: analysis of national inpatient sample data (2016-2020).
    Ann Hematol. 2025;104:1501-1506.
    PubMed     Abstract available
    
    
    
17. LAI D, Chen D, Chen X, Zhou R, et al
    Effect of major ABO blood group mismatched HSCT on blood transfusion and clinical outcomes in AA patients.
    Ann Hematol. 2025;104:1931-1947.
    PubMed     Abstract available
    
    
    
18. KARGAR M, Kaydani GA, Keikhaei B, Saki N, et al
    Association between HLA-DRB1*04, HLA-DQB1*03, and HLA-DQB1*06 with alloimmunization in transfusion-dependent patients with thalassemia: the first case-control study in Iran.
    Ann Hematol. 2025;104:1493-1499.
    PubMed     Abstract available
    
    
    
19. BODE AL, Borja-Montes OF, Quazi MA, Mumtaz A, et al
    Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis.
    Ann Hematol. 2025;104:1551-1561.
    PubMed     Abstract available
    
    
    
20. LI Y, Feng Y, Wei Y, Huang J, et al
    The impact of various types of alpha-thalassemia on perinatal complications and pregnancy outcomes in pregnant women.
    Ann Hematol. 2025;104:1541-1550.
    PubMed     Abstract available
    
    
    
21. HUANG L, Zhang Q, Ye Y, Long Y, et al
    Rapid detection of genetic modifiers of beta-thalassemia based on MALDI-TOF MS.
    Ann Hematol. 2025;104:1481-1492.
    PubMed     Abstract available
    
    
    
22. SCHNEDL WJ, Leixner G, Voill-Glaninger A, Michaelis S, et al
    Combined heterozygosity for hemoglobin Pakse, alpha-thalassemia and for hemoglobin E, beta- thalassemia ? first appearance in Europe.
    Ann Hematol. 2025;104:2059-2064.
    PubMed     Abstract available
    
    
    
23. ALHARBI M, Bawek S, Lund I, Glenn ST, et al
    Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab - case report and review of the literature.
    Ann Hematol. 2025;104:2027-2034.
    PubMed     Abstract available
    
    
    
24. TAN Z, Zhang X, Feng J, Zhao Y, et al
    Hematopoietic stem cell transplantation and immunosuppressive therapy: implications of clonal haematopoiesis.
    Ann Hematol. 2025;104:1877-1886.
    PubMed     Abstract available
    
    
    February 2025
25. CHEN L, Wei X, Zheng C, Liu X, et al
    Novel AK-1 gene variants combined with thalassemia causing rare hereditary non-spherocytic hemolytic anemia in a Chinese family.
    Ann Hematol. 2025 Feb 28. doi: 10.1007/s00277-025-06289.
    PubMed     Abstract available
    
    
    
26. YAN Q, Zhang Y, Wei L, Liu X, et al
    Assessment of anemia recovery using peripheral blood smears by deep semi-supervised learning.
    Ann Hematol. 2025 Feb 21. doi: 10.1007/s00277-025-06254.
    PubMed     Abstract available
    
    
    
27. LIU A, Jacobs-McFarlane C, Sebastiani P, Glassberg J, et al
    Plasma free hemoglobin is associated with LDH, AST, total bilirubin, reticulocyte count, and the hemolysis score in patients with sickle cell anemia.
    Ann Hematol. 2025 Feb 19. doi: 10.1007/s00277-025-06253.
    PubMed     Abstract available
    
    
    
28. CHEN X, Yu Q, Qin C, Zhang Y, et al
    Combining immunosuppressive therapy with low dosage eltrombopag in Chinese patients with severe aplastic anemia: mild aggravation of hepatic injury.
    Ann Hematol. 2025 Feb 5. doi: 10.1007/s00277-025-06210.
    PubMed     Abstract available
    
    
    
29. AMMAR M, Kmiha S, Maalej M, Felhi R, et al
    Identification of a novel truncated pathogenic variant in PUS1 gene in two siblings of consanguineous Tunisian family: intrafamilial phenotypic variability related to mtDNA copy number.
    Ann Hematol. 2025;104:943-952.
    PubMed     Abstract available
    
    
    
30. WU T, Ren Z, Liu X, Xing Z, et al
    Systematic identification and validation of ceRNA-driven regulatory mechanisms in pediatric beta-Thalassemia major.
    Ann Hematol. 2025;104:963-972.
    PubMed     Abstract available
    
    
    
31. ARLET JB, Bernaudin F, Deme-Ly I, Coulibaly B, et al
    Use of hydroxyurea in French-speaking Sub-Saharan Africa.
    Ann Hematol. 2025;104:937-941.
    PubMed     Abstract available
    
    
    
32. LIU Y, Liu M, He X, Yang L, et al
    Molecular landscape of CD8(+) T cells in pure red cell aplasia.
    Ann Hematol. 2025;104:953-961.
    PubMed     Abstract available
    
    
    
33. MAHADEVIA H, Ponvilawan B, Madan U, Sharma P, et al
    A review on disease modifying pharmacologic therapies for sickle cell disease.
    Ann Hematol. 2025;104:881-893.
    PubMed     Abstract available
    
    
    
34. XING L, Liang W, Li Y, Xiao J, et al
    Concurrent inhibited erythropoiesis in a case of VEXAS syndrome.
    Ann Hematol. 2025;104:1255-1258.
    PubMed     Abstract available
    
    
    
35. RIEDL J, Pfeilstocker M, Farr A, Hausler G, et al
    Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy- a report of two cases.
    Ann Hematol. 2025;104:1249-1253.
    PubMed     Abstract available
    
    
    
36. GOLDSCHMIDT V, Apodaca EI, Galvez KM, Wannesson B, et al
    Clinical characteristics and management of paroxysmal nocturnal haemoglobinuria in Latin America: a narrative review.
    Ann Hematol. 2025;104:867-879.
    PubMed     Abstract available
    
    
    January 2025
37. YANG K, Li Q, Zhuang X, Ma H, et al
    A retrospective analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation for transfusion-dependent beta-thalassemia: focus on T and B lymphocyte reconstitution.
    Ann Hematol. 2025 Jan 3. doi: 10.1007/s00277-024-06157.
    PubMed     Abstract available
    
    
    
38. KULASEKARARAJ A, Brodsky R, Schrezenmeier H, Griffin M, et al
    Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria.
    Ann Hematol. 2025;104:81-94.
    PubMed     Abstract available
    
    
    
39. ZHUANG J, Huang N, Zheng Y, Zhang N, et al
    First clinical and pedigree study of rare HBB: c.316-90 A > G variant in beta-globin gene in Chinese population using third-generation sequencing.
    Ann Hematol. 2025;104:75-80.
    PubMed     Abstract available
    
    
    December 2024
40. JANG T, Burnside RD, Chaffin J, Seifert R, et al
    Severe aplastic anemia with acquired X chromosome clonality as a sole abnormality.
    Ann Hematol. 2024 Dec 31. doi: 10.1007/s00277-024-06166.
    PubMed     Abstract available
    
    
    
41. GAO M, Huang X, Gao S, Wang S, et al
    Similar outcomes between HLA-haploid and matched sibling donor hematopoietic stem cell transplantation: a multicenter, retrospective study and severe aplastic anemia transplant-specific prognostic scoring system.
    Ann Hematol. 2024 Dec 12. doi: 10.1007/s00277-024-06051.
    PubMed     Abstract available
    
    
    
42. PINES M, Kleinert D, Thomas C, Mensah C, et al
    Real-world experience with iron chelation therapy in transfusion-dependent thalassemia: impact of the oral chelators' era.
    Ann Hematol. 2024;103:5229-5234.
    PubMed     Abstract available
    
    
    
43. DAWUDI Y, Azoyan L, Bonjour M, Steichen O, et al
    COVID-19 outcomes among patients with sickle cell disease or sickle cell trait compared to the general population: a systematic review and meta-analyses.
    Ann Hematol. 2024;103:5071-5083.
    PubMed     Abstract available
    
    
    
44. DINGLI D, Rizio AA, Broderick L, LaGasse K, et al
    Health-related quality of life and symptom-specific functional impairment among patients treated with parenterally administered complement inhibitors for paroxysmal nocturnal hemoglobinuria.
    Ann Hematol. 2024;103:5213-5227.
    PubMed     Abstract available
    
    
    
45. FAN L, Cao L, Luo Y, Gao F, et al
    Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury.
    Ann Hematol. 2024;103:5925-5927.
    PubMed     Abstract available
    
    
    
46. MOTTA I, Delbini P, Scaramellini N, Ghiandai V, et al
    Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease.
    Ann Hematol. 2024;103:5113-5121.
    PubMed     Abstract available
    
    
    
47. GUO X, Lin S, Zhang X, Li M, et al
    Integrated metabolomic and microbiome analysis identifies Cupriavidus metallidurans as a potential therapeutic target for beta-thalassemia.
    Ann Hematol. 2024;103:5169-5179.
    PubMed     Abstract available
    
    
    November 2024
48. LOH JB, Ross JM, Musallam KM, Kuo KHM, et al
    Trans-acting genetic modifiers of clinical severity in heterozygous beta-Thalassemia trait.
    Ann Hematol. 2024;103:4437-4447.
    PubMed     Abstract available
    
    
    
49. DE SANTIS M, Tonutti A, Motta F, Todisco G, et al
    Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate.
    Ann Hematol. 2024;103:4789-4791.
    PubMed     Abstract available
    
    
    October 2024
50. CAHUAPAZA-GUTIERREZ NL
    Aplastic Anemia in the light of the COVID-19 pandemic: infection, vaccination, and pathophysiologic mechanisms.
    Ann Hematol. 2024 Oct 23. doi: 10.1007/s00277-024-06052.
    PubMed     Abstract available
    
    
    
51. DONGERDIYE R, Kedar PS, Saptarshi A, Sampagar A, et al
    Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patients.
    Ann Hematol. 2024;103:3987-3998.
    PubMed     Abstract available
    
    
    
52. ZHANG M, Liu M, Yang L, Liu Y, et al
    Increased ferroptosis of erythrocytes is associated with myelodysplastic syndromes.
    Ann Hematol. 2024;103:4009-4020.
    PubMed     Abstract available
    
    
    September 2024
53. CHEN WT, Wang SW, Huang Y, Tang RM, et al
    The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia.
    Ann Hematol. 2024 Sep 5. doi: 10.1007/s00277-024-05964.
    PubMed     Abstract available
    
    
    
54. EBEID FSE, Aly NH, Shaheen NM, Abdellatif SMA, et al
    Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study.
    Ann Hematol. 2024;103:3493-3506.
    PubMed     Abstract available
    
    
    
55. EZZAT EM, Bakr S, Golam RM, Abdelgyed BA, et al
    Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes.
    Ann Hematol. 2024;103:3473-3482.
    PubMed     Abstract available
    
    
    
56. JAJODIA E, Menghani H, Arora N, Jitani A, et al
    De-novo ATR-16 syndrome associated with inherited hemoglobin Evanston causing HbH phenotype: a rare occurrence.
    Ann Hematol. 2024;103:3805-3810.
    PubMed     Abstract available
    
    
    
57. PATSOURAKOS D, Aggeli C, Dimitroglou Y, Delicou S, et al
    Speckle tracking echocardiography and beta-thalassemia major. A systematic review.
    Ann Hematol. 2024;103:3335-3356.
    PubMed     Abstract available
    
    
    August 2024
58. SHEN S, Hu Q, Yang C, Jiang Z, et al
    Adding hetrombopag to cyclosporine a improved response of patients with newly diagnosed transfusion-dependent non-severe aplastic anemia.
    Ann Hematol. 2024 Aug 23. doi: 10.1007/s00277-024-05941.
    PubMed    
    
    
    
59. LI X, Shangguan X, Wang H, Wang Q, et al
    Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.
    Ann Hematol. 2024 Aug 1. doi: 10.1007/s00277-024-05910.
    PubMed     Abstract available
    
    
    
60. IQBAL N, Meghani MA, Khalid W, Ansari AH, et al
    Transcobalamin deficiency - a rare genetic defect in transportation of cobalamin; case report.
    Ann Hematol. 2024;103:3243-3246.
    PubMed     Abstract available
    
    
    
61. FUREDER W, Valent P
    Stable responses to danicopan as add-on to ravulizumab in two patients with paroxysmal nocturnal hemoglobinuria.
    Ann Hematol. 2024;103:3235-3238.
    PubMed    
    
    
    
62. MARCO SANCHEZ JM, Bardon Cancho EJ, Beneitez D, Payan-Pernia S, et al
    Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR).
    Ann Hematol. 2024;103:2743-2755.
    PubMed     Abstract available
    
    
    
63. YANG J, Shi X, Liu X, Qiao X, et al
    STK10 mutations block erythropoiesis in acquired pure red cell aplasia via impairing ribosome biogenesis.
    Ann Hematol. 2024;103:2711-2720.
    PubMed     Abstract available
    
    
    
64. BHANGU G, Uminski K, Roessner C, Goodyear D, et al
    Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report.
    Ann Hematol. 2024;103:3277-3279.
    PubMed    
    
    
    
65. LI J, Lv A, Chen M, Xu L, et al
    Activating transcription factor 4 in erythroid development and beta -thalassemia: a powerful regulator with therapeutic potential.
    Ann Hematol. 2024;103:2659-2670.
    PubMed     Abstract available
    
    
    
66. YOUSSRY I, Ayad N
    Sickle cell disease: combination new therapies vs. CRISPR-Cas9 potential and challenges - review article.
    Ann Hematol. 2024;103:2613-2619.
    PubMed     Abstract available
    
    
    
67. KIRTHAN JPA, Somannavar MS
    Pathophysiology and management of iron deficiency anaemia in pregnancy: a review.
    Ann Hematol. 2024;103:2637-2646.
    PubMed     Abstract available
    
    
    July 2024
68. MUSALLAM KM, Barella S, Origa R, Ferrero GB, et al
    Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent beta-thalassemia: a 10-year cohort study.
    Ann Hematol. 2024;103:2283-2297.
    PubMed     Abstract available
    
    
    
69. TER AVEST M, Langemeijer SMC, Blijlevens NMA, van de Kar NCAJ, et al
    Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplan.
    Ann Hematol. 2024;103:2267-2272.
    PubMed     Abstract available
    
    
    June 2024
70. GONG Y, Li Y, Chen X, Yang H, et al
    Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib.
    Ann Hematol. 2024 Jun 27. doi: 10.1007/s00277-024-05856.
    PubMed     Abstract available
    
    
    
71. WANG L, Fang L, Shi H, Liu Y, et al
    Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study.
    Ann Hematol. 2024 Jun 22. doi: 10.1007/s00277-024-05847.
    PubMed     Abstract available
    
    
    
72. KANTER J, Ataga KI, Bhasin N, Guarino S, et al
    Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel.
    Ann Hematol. 2024;103:1909-1917.
    PubMed     Abstract available
    
    
    
73. ZHANG Z, Hu Q, Yang C, Chen M, et al
    Comparison of human leukocyte antigen in patients with paroxysmal nocturnal hemoglobinuria of different clone sizes.
    Ann Hematol. 2024;103:1897-1907.
    PubMed     Abstract available
    
    
    
74. MELONI A, Pistoia L, Ricchi P, Bagnato S, et al
    Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent beta-thalassemia intermedia.
    Ann Hematol. 2024;103:1887-1896.
    PubMed     Abstract available
    
    
    
75. YANG L, Niu H, Zhang T, Cao Q, et al
    A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia.
    Ann Hematol. 2024;103:1877-1885.
    PubMed     Abstract available
    
    
    
76. ALAYOUBI AM, Khawaji ZY, Mohammed MA, Mercier FE, et al
    CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia.
    Ann Hematol. 2024;103:1805-1817.
    PubMed     Abstract available
    
    
    May 2024
77. SHI Y, Zhao Y, Liang W, Zhang B, et al
    A preliminary study of roxadustat in the treatment of aplastic anemia patients with inadequate erythroid responses.
    Ann Hematol. 2024 May 22. doi: 10.1007/s00277-024-05799.
    PubMed     Abstract available
    
    
    
78. NAKAMURA Y, Zaimoku Y, Yamaguchi H, Yamazaki H, et al
    Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia.
    Ann Hematol. 2024 May 16. doi: 10.1007/s00277-024-05800.
    PubMed     Abstract available
    
    
    
79. BARDON-CANCHO EJ, Marco-Sanchez JM, Beneitez-Pastor D, Payan-Pernia S, et al
    Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with beta-thalassemia.
    Ann Hematol. 2024;103:1525-1539.
    PubMed     Abstract available
    
    
    
80. AL-KURAISHY HM, Mazhar Ashour MH, Saad HM, Batiha GE, et al
    COVID-19 and beta-thalassemia: in lieu of evidence and vague nexus.
    Ann Hematol. 2024;103:1423-1433.
    PubMed     Abstract available
    
    
    April 2024
81. HU M, Li J, Liu R, Zhang Z, et al
    Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series.
    Ann Hematol. 2024 Apr 24. doi: 10.1007/s00277-024-05756.
    PubMed     Abstract available
    
    
    
82. QIN S, Jiang Y, Ou Y, Zhan Y, et al
    Mendelian randomization of circulating proteome identifies IFN-gamma as a druggable target in aplastic anemia.
    Ann Hematol. 2024 Apr 22. doi: 10.1007/s00277-024-05746.
    PubMed     Abstract available
    
    
    
83. LOMMERSE IN, Hinnen C, van Vliet LM, Schubert B, et al
    Quality of life after immune suppressive therapy in aplastic anemia.
    Ann Hematol. 2024 Apr 5. doi: 10.1007/s00277-024-05731.
    PubMed     Abstract available
    
    
    
84. DE CASTRO JNP, da Silva Costa SM, Camargo ACL, Ito MT, et al
    Comparative transcriptomic analysis of circulating endothelial cells in sickle cell stroke.
    Ann Hematol. 2024;103:1167-1179.
    PubMed     Abstract available
    
    
    
85. SHARMA A, Kumar A, Saha PK, Saha L, et al
    The role of TMPRSS6 gene polymorphism in iron resistance iron deficiency anaemia (IRIDA): a systematic review.
    Ann Hematol. 2024;103:1085-1102.
    PubMed     Abstract available
    
    
    
86. WANG J, Zhu H, Miao K
    Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report.
    Ann Hematol. 2024 Apr 1. doi: 10.1007/s00277-024-05714.
    PubMed     Abstract available
    
    
    March 2024
87. VALLEJO C, Rosell A, Xicoy B, Garcia C, et al
    A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study).
    Ann Hematol. 2024;103:705-713.
    PubMed     Abstract available
    
    
    
88. LEONI S, Bou-Fakhredin R, Granata F, Cassinerio E, et al
    Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with beta-thalassemia.
    Ann Hematol. 2024;103:1025-1026.
    PubMed    
    
    
    February 2024
89. SECK M, Manal B, Toure SA, Keita M, et al
    Challenges in the management of iron-deficiency anemia in Senegal, West Africa.
    Ann Hematol. 2024 Feb 3. doi: 10.1007/s00277-024-05626.
    PubMed    
    
    
    
90. ZHA Q, Shi Y, Shi Z, Huang F, et al
    Loeys-Dietz syndrome with concomitant aplastic anemia.
    Ann Hematol. 2024 Feb 2. doi: 10.1007/s00277-024-05637.
    PubMed    
    
    
    
91. SONGDEJ D, Surapolchai P, Komwilaisak P, Sripornsawan P, et al
    Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi-center registry.
    Ann Hematol. 2024;103:385-393.
    PubMed     Abstract available
    
    
    
92. GARCIA-MORIN M, Bardon-Cancho EJ, Belendez C, Dulin E, et al
    Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival.
    Ann Hematol. 2024;103:373-383.
    PubMed     Abstract available
    
    
    
93. MURAKHOVSKAYA I, Crivera C, Leon A, Alemao E, et al
    Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab.
    Ann Hematol. 2024 Feb 1. doi: 10.1007/s00277-023-05613.
    PubMed     Abstract available
    
    
    January 2024
94. CHATTOPADHYAY S, Lionel S, Selvarajan S, Devasia AJ, et al
    Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival.
    Ann Hematol. 2024 Jan 20. doi: 10.1007/s00277-024-05621.
    PubMed     Abstract available
    
    
    
95. ZHANG Z, Wang X, Jiang J
    Screening results and mutation frequency analysis of G6PD deficiency in 1,291,274 newborns in Huizhou, China: a twenty-year experience.
    Ann Hematol. 2024;103:29-36.
    PubMed     Abstract available
    
    
    
96. ZULLO A, De Francesco V, Gatta L, Scaccianoce G, et al
    Small bowel lesions in patients with iron deficiency anaemia without overt bleeding: a multicentre study.
    Ann Hematol. 2024;103:1-4.
    PubMed     Abstract available
    
    
    
97. SCHREZENMEIER H, Kulasekararaj A, Mitchell L, de Latour RP, et al
    Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria.
    Ann Hematol. 2024;103:5-15.
    PubMed     Abstract available
    
    
    December 2023
98. DELGADINHO M, Veiga L, Ginete C, Santos B, et al
    Differential expression of adhesion molecules in sickle cell anemia and gut microbiome effect.
    Ann Hematol. 2023 Dec 28. doi: 10.1007/s00277-023-05589.
    PubMed     Abstract available
    
    
    
99. FU L, Zhang J, Wang R, Yang B, et al
    Clinical characteristics of hepatitis-associated aplastic anemia in children.
    Ann Hematol. 2023 Dec 12. doi: 10.1007/s00277-023-05566.
    PubMed     Abstract available
    
    
    
100. MCBRIDE HJ, Frazer-Abel A, Thiemann S, Lehto SG, et al
     Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD.
     Ann Hematol. 2023;102:3299-3309.
     PubMed     Abstract available
     
     
     November 2023
101. GONG Y, Zhang X, Chen X, Yang H, et al
     Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab.
     Ann Hematol. 2023 Nov 27. doi: 10.1007/s00277-023-05549.
     PubMed    
     
     
     
102. STRASSER B, Heibl S, Hormann G, Haushofer A, et al
     Diamond-Blackfan anemia with very late and fatal onset aplasia in a 55-year-old patient with RPL11 mutation.
     Ann Hematol. 2023 Nov 23. doi: 10.1007/s00277-023-05553.
     PubMed    
     
     
     
103. KITAMURA W, Kobayashi H, Iseki A, Wada H, et al
     Cold agglutinin-induced acrocyanosis without hemolytic anemia.
     Ann Hematol. 2023 Nov 9. doi: 10.1007/s00277-023-05538.
     PubMed    
     
     
     
104. POPE V, Hsia CC
     Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia.
     Ann Hematol. 2023 Nov 6. doi: 10.1007/s00277-023-05535.
     PubMed    
     
     
     
105. LOUZAO M, Vargas MT, Meseguer E, Pedrote Amador B, et al
     Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation.
     Ann Hematol. 2023;102:3283-3284.
     PubMed    
     
     
     
106. SUN XH, Liu Q, Wu SN, Xu WH, et al
     Cytopenia: a report of haplo-cord transplantation in twin brothers caused by a novel germline GATA1 mutation and family survey.
     Ann Hematol. 2023;102:3177-3184.
     PubMed     Abstract available
     
     
     
107. VALLEE T, Schmid I, Gloning L, Bacova M, et al
     Excellent outcome of stem cell transplantation for sickle cell disease.
     Ann Hematol. 2023;102:3217-3227.
     PubMed     Abstract available
     
     
     
108. HOCHSMANN B, Peffault de Latour R, Hill A, Roth A, et al
     Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case-control study in the International PNH Registry.
     Ann Hematol. 2023;102:2979-2988.
     PubMed     Abstract available
     
     
     October 2023
109. SI T, Ma X, Zhu W, Zhou Y, et al
     Comment on: Association between anemia and depression: results from NHANES 2005-2018 and Mendelian randomization analyses.
     Ann Hematol. 2023 Oct 21. doi: 10.1007/s00277-023-05496.
     PubMed    
     
     
     
110. KURITA N, Nishikii H, Maruyama Y, Suehara Y, et al
     Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial.
     Ann Hematol. 2023;102:2895-2902.
     PubMed     Abstract available
     
     
     
111. DEENADAYALAN V, Litvin R, Vakil J, Kanemo P, et al
     Recent national trends in outcomes and economic disparities among adult sickle cell disease-related admissions.
     Ann Hematol. 2023;102:2659-2669.
     PubMed     Abstract available
     
     
     
112. ROCCOTELLI D, Grande D, Cicco G, Palma A, et al
     Real-life experience with luspatercept in transfusion-dependent beta-thalassemia.
     Ann Hematol. 2023;102:2965-2967.
     PubMed    
     
     
     
113. CAN F, Yilmaz KN, Kosemehmetoglu OS, Akinci S, et al
     Comparison of different intravenous iron preparations in terms of total oxidant and total antioxidant status, single center data.
     Ann Hematol. 2023;102:2645-2650.
     PubMed     Abstract available
     
     
     September 2023
114. YOUSSEF MAM, Ghazaly MH, Abdelfattah MA
     Alternative treatment modality for severe aplastic anemia in a resource-limited setting: a single-institution prospective cohort study from Upper Egypt.
     Ann Hematol. 2023 Sep 13. doi: 10.1007/s00277-023-05440.
     PubMed     Abstract available
     
     
     
115. CHEN M, Ataga KI, Hankins JS, Zhang M, et al
     Age-related differences in risks and outcomes of 30-day readmission in adults with sickle cell disease.
     Ann Hematol. 2023;102:2329-2342.
     PubMed     Abstract available
     
     
     
116. SHOME DK, Das P, Akbar GA, Taha S, et al
     Molecular insights into hereditary elliptocytosis and pyropoikilocytosis: NGS uncovers multiple potential candidate genes.
     Ann Hematol. 2023;102:2343-2351.
     PubMed     Abstract available
     
     
     
117. GREWAL US, Thotamgari SR, Gaddam SJ, Lakra R, et al
     Characteristics and outcomes associated with venous thrombotic complications among patients with paroxysmal nocturnal hemoglobinuria.
     Ann Hematol. 2023;102:2631-2632.
     PubMed    
     
     
     
118. HAYASHINO K, Fujiwara Y, Isokane Y, Tobita H, et al
     Paroxysmal nocturnal hemoglobinuria with ulcerative colitis.
     Ann Hematol. 2023;102:2625-2626.
     PubMed    
     
     
     August 2023
119. SORIN B, Fadlallah J, Garzaro M, Vigneron J, et al
     Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia.
     Ann Hematol. 2023;102:2059-2068.
     PubMed     Abstract available
     
     
     
120. VIPRAKASIT V, Hamdy MM, Hassab HMA, Sherief LM, et al
     Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia.
     Ann Hematol. 2023;102:2039-2049.
     PubMed     Abstract available
     
     
     
121. MUSALLAM KM, Ahmed W, Almarshoodi MO, Trad O, et al
     Establishment of the Abu Dhabi Emirate Thalassemia Longitudinal Cohort (AD-TLC): leveraging the power of observation.
     Ann Hematol. 2023;102:2277-2278.
     PubMed    
     
     
     
122. SHIMAZU Y, Mizumoto C, Chonabayashi K, Hanyu Y, et al
     Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy.
     Ann Hematol. 2023;102:2291-2292.
     PubMed    
     
     
     July 2023
123. WANG Y, Guo D, Sui C, Qu Z, et al
     Association between anemia and depression: results from NHANES 2005-2018 and mendelian randomization analyses.
     Ann Hematol. 2023 Jul 22. doi: 10.1007/s00277-023-05374.
     PubMed     Abstract available
     
     
     
124. HAMMAMI MB, Qasim A, Thakur R, Vegivinti CTR, et al
     Rasburicase-induced hemolytic anemia and methemoglobinemia: a systematic review of current reports.
     Ann Hematol. 2023 Jul 19. doi: 10.1007/s00277-023-05364.
     PubMed     Abstract available
     
     
     
125. LIN F, Dong X, Zhang Y, Cheng Y, et al
     Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia.
     Ann Hematol. 2023 Jul 13. doi: 10.1007/s00277-023-05332.
     PubMed     Abstract available
     
     
     
126. ZHAO J, Ma L, Zheng M, Su L, et al
     Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia.
     Ann Hematol. 2023 Jul 13. doi: 10.1007/s00277-023-05339.
     PubMed     Abstract available
     
     
     
127. BODLA ZH, Hashmi M, Niaz F, Farooq U, et al
     Timing matters: An analysis of the relationship between red cell transfusion timing and hospitalization outcomes in sickle cell crisis patients using the National Inpatient Sample database.
     Ann Hematol. 2023;102:1669-1676.
     PubMed     Abstract available
     
     
     
128. DINGLI D, Maciejewski JP, Larratt L, Go RS, et al
     Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry.
     Ann Hematol. 2023;102:1637-1644.
     PubMed     Abstract available
     
     
     
129. AU TY, Wisniewski OW, Benjamin S, Kubicki T, et al
     G6PD deficiency-does it alter the course of COVID-19 infections?
     Ann Hematol. 2023;102:1629-1636.
     PubMed     Abstract available
     
     
     June 2023
130. CANNAS G, Poutrel S, Heiblig M, Labussiere H, et al
     Sickle cell disease and acute leukemia: one case report and an extensive review.
     Ann Hematol. 2023 Jun 3:1-11. doi: 10.1007/s00277-023-05294.
     PubMed     Abstract available
     
     
     May 2023
131. ARAUJO COSTA E, de Paula Ayres-Silva J
     Global profile of anemia during pregnancy versus country income overview: 19 years estimative (2000-2019).
     Ann Hematol. 2023 May 26. doi: 10.1007/s00277-023-05279.
     PubMed     Abstract available
     
     
     
132. WU LQ, Huang LF, Yang H, Ye BD, et al
     Comparison of haploidentical-allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study.
     Ann Hematol. 2023 May 17. doi: 10.1007/s00277-023-05256.
     PubMed     Abstract available
     
     
     
133. NIU H, Yan L, Yang L, Zhang M, et al
     High TOX expression on CD8(+) T cells in pure red cell aplasia.
     Ann Hematol. 2023;102:1247-1255.
     PubMed     Abstract available
     
     
     
134. DONGERDIYE R, Bokde M, More TA, Saptarshi A, et al
     Targeted next-generation sequencing identifies eighteen novel mutations expanding the molecular and clinical spectrum of PKLR gene disorders in the Indian population.
     Ann Hematol. 2023;102:1029-1036.
     PubMed     Abstract available
     
     
     
135. BELISARIO AR, Simoes E Silva AC, Moura ICG, Carneiro-Proietti AB, et al
     Estimated glomerular filtration rate in Brazilian adults with sickle cell disease: results from the REDS-III multicenter cohort study.
     Ann Hematol. 2023;102:1019-1027.
     PubMed     Abstract available
     
     
     April 2023
136. ABDEL-SALAM A, Bassiouni ST, Goher AM, Shafie ES, et al
     Autoimmune Hemolytic Anemia in the Pediatric Age Group: The Egyptian Experience.
     Ann Hematol. 2023 Apr 24. doi: 10.1007/s00277-023-05230.
     PubMed     Abstract available
     
     
     
137. TSILIKA M, Mitrou J, Antonakos N, Tseti IK, et al
     An active new formulation of iron carried by aspartyl casein for iron-deficiency anemia: results of the ACCESS trial.
     Ann Hematol. 2023 Apr 6. doi: 10.1007/s00277-023-05197.
     PubMed     Abstract available
     
     
     
138. JONGKRAIJAKRA S, Doungngern T, Sripakdee W, Lekhakula A, et al
     A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia.
     Ann Hematol. 2023 Apr 3:1-8. doi: 10.1007/s00277-023-05198.
     PubMed     Abstract available
     
     
     
139. IGLESIAS-VAZQUEZ L, Gimeno M, Coronel P, Caspersen IH, et al
     Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study.
     Ann Hematol. 2023;102:741-748.
     PubMed     Abstract available
     
     
     
140. ZHANG Y, Pan J, Kang H, Peng S, et al
     Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments.
     Ann Hematol. 2023;102:801-809.
     PubMed     Abstract available
     
     
     March 2023
141. YANG K, Nie W, Huang Q, Liao G, et al
     Hematopoietic cell transplantation for congenital dyserythropoietic anemia IV caused by compound heterozygous KLF1 mutations.
     Ann Hematol. 2023 Mar 31. doi: 10.1007/s00277-023-05175.
     PubMed    
     
     
     
142. DING K, Liu Z, Ren Y, Liu H, et al
     Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients.
     Ann Hematol. 2023 Mar 13. doi: 10.1007/s00277-022-04997.
     PubMed    
     
     
     
143. AHMADI M, Beiranvand S, Poormansouri S, Matbouei M, et al
     Sense of coherence or self-efficacy as predictors of health-related quality of life in sickle cell disease patients.
     Ann Hematol. 2023;102:519-528.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.